Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children
Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Technetium-99m-hydrazinonicotinamide-Tyr
3
-octreotide (
99m
Tc-HYNIC-TOC) is recognized as a promising radiopharmaceutical for diagnosing neuroendocrine tumors (NETs). However,
99m
Tc-HYNIC-TOC dosimetry has been investigated only for adults. As pediatric radionuclide therapies become increasingly common, similar do...
Alternative Titles
Full title
Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dbfc2e758881482b8aa1b86e3eab99f3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dbfc2e758881482b8aa1b86e3eab99f3
Other Identifiers
ISSN
2197-7364
E-ISSN
2197-7364
DOI
10.1186/s40658-017-0191-6
